STOP HIV/AIDS

Oct-09

NIDA invests $50 million to evaluate made-in-BC strategy for control of HIV/AIDS The US National Institute on Drug Abuse (NIDA) intends to fund research worth up to US$50 million over five years to evaluate the “seek-and-treat” strategy originally developed at the BC Centre for Excellence in HIV/AIDS (BC-CfE). NIDA has issued a Request for Applications

Oct-09 Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below